RecruitingNCT07372820
METABolic Deterioration in HTX Determines Outcomes
METAB-HTX: Prospective, Longitudinal Cohort Study Evaluationg Cardiac and Systemic Metabolism After Heart Transplantation
Sponsor
Heinrich-Heine University, Duesseldorf
Enrollment
270 participants
Start Date
Jul 24, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age: ≥ 18 years
- Planned or already conducted heart transplantation
- Informed consent
Exclusion Criteria1
- Absence of informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07372820
Related Trials
Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease
NCT063252801 location
Pericoronary Adipocyte Size Gradient
NCT073609251 location
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
NCT070969731 location
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
NCT068134433 locations
Electronic Register on Advanced Heart Failure and Transplantation di Cuore
NCT067736111 location